- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.01. | Biogen offers to buy out wilting Sage for $442 million | ||
| 10.01. | Ouro makes debut with $120m for autoimmune disease TCEs | ||
| 10.01. | Algorithm spots common sleep disorder linked to dementia | ||
| 10.01. | CRISPR biotech Intellia cuts staff as it eyes 2027 launch | ||
| 10.01. | World's largest proteomics trial launched by UK Biobank | ||
| 09.01. | EU pharma calls for speedy shift to digital package inserts | ||
| 09.01. | UK 'needs more transparency on pharma-doctor payments' | ||
| 09.01. | Verdiva Bio raises $411m for obesity pipeline | ||
| 09.01. | AMD shadows NVIDIA with a move into AI drug discovery | ||
| 09.01. | Grifols files drug for rare bleeding disorder in the US | ||
| 09.01. | Is GSK prepping a $1bn takeover bid for IDRx? | ||
| 08.01. | Novo Nordisk swells alliance with AI firm Valo Health | ||
| 08.01. | Galapagos unveils plan to split, hiving off its drugs unit | ||
| 08.01. | 11 blockbuster drugs to look out for in 2025 | ||
| 08.01. | Aviceda raises $207.5m for eye drug, and other financings | ||
| 08.01. | J&J says Rybrevant combo has survival edge over Tagrisso | ||
| 07.01. | Verona says COPD drug is off to a flying start | ||
| 07.01. | GSK bags breakthrough status for bone cancer drug | ||
| 07.01. | FDA issues first guidance on AI in medicine development | ||
| 07.01. | Denali slides after ALS drug flunks clinical test | ||
| 07.01. | US reports its first fatal case of H5N1 bird flu | ||
| 06.01. | MSD buys Irish vaccines plant from WuXi for €500m | ||
| 06.01. | NeOnc Technologies has another go at a Nasdaq listing | ||
| 06.01. | UK plan to tackle waiting lists includes NHS App upgrade | ||
| 06.01. | UK public urged to take up flu jabs as cases surge |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
